First-pass extracted concept

blood-retinal barrier

Candidate: concept label1 source documents3 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

BRB

Extracted Explainers

What the tool is doing

The blood-retinal barrier is presented as a central barrier system whose disruption accompanies vascular damage in aging-related eye disease.

Source 1DOI PubMed

What problem it solves

As a review concept, it helps explain how vascular injury may connect to neuronal degeneration and vision loss.

Source 1DOI PubMed

What it does not solve

The abstract does not identify a specific BRB-targeting therapeutic tool, assay, or construct.

Source 1DOI PubMed

Alternatives

The abstract also highlights insufficient blood supply, mitochondrial dysfunction, altered cellular communication, and aggregated protein accumulation as related mechanisms.

Source 1DOI PubMed

Evidence Snippets

Damage to blood vessels is related to the disruption of the blood-retinal barrier (BRB)... Vascular complications, such as insufficient blood supply and BRB disruption, have been suggested to play a role in glaucoma, age-related macular degeneration (AMD), and Alzheimer's disease (AD), resulting in neuronal cell death.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2022International Journal of Molecular SciencesDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1disease associationsupports2022Source 1DOI PubMed

Vascular complications including insufficient blood supply and blood-retinal barrier disruption have been suggested to contribute to glaucoma, age-related macular degeneration, and Alzheimer's disease, resulting in neuronal cell death.

Claim 2mechanistic associationsupports2022Source 1DOI PubMed

Damage to ocular blood vessels is associated with blood-retinal barrier disruption, altered cellular communication, disrupted mitochondrial function, and exacerbated aggregated protein accumulation.

Claim 3therapeutic directionsupports2022Source 1DOI PubMed

Beneficial molecular pathways to prevent or slow retinal pathologic processes are discussed as a therapeutic direction in aging-related eye disease.